Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.64
$0.092.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.93% | -36.44% | -124.54% | -20.74% | -25.85% |
| Total Depreciation and Amortization | 23.53% | -56.43% | -105.88% | -52.29% | -51.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 337.66% | 453.66% | 1,388.79% | 195.93% | -2,180.39% |
| Change in Net Operating Assets | 90.97% | 131.84% | -687.60% | -437.60% | 53.52% |
| Cash from Operations | 3.17% | -0.18% | -29.54% | -43.04% | -7.32% |
| Capital Expenditure | -- | 67.57% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 100.00% | -99.99% | 318.84% |
| Cash from Investing | -- | -100.05% | 99.96% | -99.99% | 318.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -63.38% | 78,714.71% | -53.68% | -98.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6,580.00% | -235.12% | 103,448.53% | -53.68% | -99.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -255.69% | -234.46% | 245.92% | -386.06% | 176.32% |